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Abstract 14 
The production of viable functional probiotics presupposes stability of strain features in the 15 
final product. In this study it was evaluated the effect of acquisition of heat-tolerance and 16 
freeze-drying on the adhesion properties of Lactobacillus rhamnosus GG, Lactobacillus casei 17 
Shirota, Bifidobacterium lactis Bb-12 and Bifidobacterium animalis IF20/1 and on their 18 
ability to inhibit the adhesion of pathogens in a mucus model. Both fresh and freeze-dried 19 
cultures were evaluated. Significant differences were observed between fresh, freeze dried, 20 
fresh heat-tolerant and freeze dried heat- tolerant strains, especially in the ability of the freeze 21 
dried probiotics to exclude, displace or outcompete pathogens.  22 
Based on our study characterizing probiotic properties such as adhesion and competitive 23 
exclusion, it seems possible to adapt probiotics to processing stresses, such as heat, without 24 
significantly changing the probiotic properties of the strains assessed. This may provide new 25 
options for future probiotic production technology. However, our results also emphasize that 26 
the properties of the stress-adapted strains, as well as the effect of the production processes 27 
should always be assessed as these are strain-specific. 28 
Keywords: probiotics, adhesion, heat-tolerant, exclude, displace, outcompete.  29 
 30 
 31 
1.1. Introduction 32 
Probiotics have been defined as “Live microorganisms which when administered in adequate 33 
amounts confer a health benefit on the host” (FAO/WHO; 2001) and usually belong to the 34 
genus Lactobacillus or Bifidobacterium. Temporary colonization of the intestinal tract is a 35 
critical property of a probiotic (Alander et al. 1999). Colonization should be a probiotic 36 
property by which the intestinal mucosa may provide the host with protection by 37 
competitively excluding pathogens through competition for binding sites and nutrients, or by 38 
production of antimicrobials (Collado et al. 2005).Probiotic properties have been defined on a 39 
strain to strain basis and quality control should be focused on these properties and care should 40 
be taken to keep the original properties intact (Tuomola et al. 2000).  However, recently 41 
Grzeskowiak and coworkers (2011) demonstrated that even the same strain properties may 42 
change depending on the manufacturing and processing conditions.  43 
The definition of a probiotic includes the clause “in adequate amounts” and although this is 44 
not a known exact number, high levels of viable microorganisms are recommended for a 45 
beneficial effect to be seen (Knorr, 1998). The “adequate amount” of each probiotic varies 46 
and may also depend on the production technology used i.e. freeze dried in milk or 47 
encapsulated in calcium alginate, for example (Saxelin et al. 2010). Currently there is not a 48 
uniform dosing or frequency of dosing recommendation, with ranges of 2 x 10
7 –
 3.2 x 10
12 49 
colony forming units being used (Caglar et al. 2006, Gionchetti et al. 2007, Wallace et al. 50 
2011). 
 
Consequently, the retention of high viability during drying and storage is imperative 51 
and challenging and the need to study each potential probiotic strain or mix of strains 52 
separately is necessary.  53 
The production of viable functional probiotics presupposes stability of strain features in the 54 
final product. To achieve this, pre-exposing the probiotics to stress has been reported 55 
potentially beneficial in gradually modifying heat-, bile- and acid-tolerance (Berger et al. 56 
2010; Collado and Sanz 2006; Margolles et al. 2003). However, as it has been previously 57 
shown in bile and acid adapted strains this may influence the strain properties significantly 58 
(Collado et al. 2006; Gueimonde et al. 2005; 2007). The aim of this study was to produce 59 
process stable probiotic strains, specifically heat resistant strains, and to study the effect of 60 
heat resistance acquisition and freeze-drying on the adhesion of the strains to human colonic 61 
mucus, as well as their ability to inhibit, compete with and displace the adhesion of five 62 
common model pathogens.  63 
For this purpose we obtained heat-tolerant derivatives from common probiotic strains and 64 
evaluated their adhesion properties and their ability to exclude, displace or outcompete 65 
pathogens in a mucus model. To this end both fresh and freeze-dried bacteria were tested. We 66 
hypothesised that the strain properties stay similar to those of the original isolates when 67 
gradually adapted to heat. 68 
  69 
1.2. Material and Methods 70 
1.2.1. Bacterial strains and culture conditions 71 
Lactobacilli and bifidobacteria used in this study were Lactobacillus rhamnosus GG (ATCC 72 
53013), Lactobacillus casei Shirota (isolated from Yakult®, Tokyo, Japan), Bifidobacterium 73 
lactis Bb-12 (Christian Hansen, Hørsholm, Denmark) and B. animalis IF20/1, isolated from 74 
the feces of a 2-day old, vaginally delivered, breast-fed infant.  The microorganisms were 75 
cultured from a frozen stock by inoculating Man Rogosa Sharpe (MRS) broth (Difco, Detroit, 76 
MI, USA) with a 1 % inoculum and incubated at 37 °C for 48 h under anaerobic conditions. 77 
Heat-shocked (HS) derivatives of these strains were obtained by successive 10 min heat-78 
shocks, of resuspended cells in Phosphate buffered saline (PBS, pH 7,2), at increasing 79 
temperatures starting from 60 °C and incrementing the temperature by 5 °C in each 80 
successive shock. After each shock cells were inoculated to fresh media followed by recovery 81 
at 37 °C until the stationary phase of the growth was obtained as earlier studies have shown 82 
that stationary phase cultures are more resistant to heat stress (Kim et al. 2001; Saarela et al. 83 
2004). The heat-treatment was stopped when no colonies were able to survive after heat 84 
treatment. With this selection process, the Lactobacillus rhamnosus GG derivative strain was 85 
obtained at temperature 85 °C, the Lactobacillus casei Shirota derivative strain was obtained 86 
at temperature 80 °C, the Bifidobacterium lactis Bb-12 derivative strain was obtained at 87 
temperature 70 °C and the Bifidobacterium animalis IF20/1 derivative strain was obtained at 88 
temperature 85 °C. All bacteria were metabolically labelled by addition to the media of 10 µl 89 
ml
-1
 tritiated thymidine (5-
3
H-thymidine 1.0 mCi/ml; Amersham Biosciences, UK) and 90 
incubated overnight under anaerobic conditions at 37 °C.  91 
Fresh and freeze-dried cultures from the different strains were assessed. To obtain fresh 92 
cultures, MRS media containing 10 µl ml
-1
 tritiated thymidine was inoculated at 1 % with a 93 
preinoculum and incubated overnight for labelling. For freeze-drying, bacterial biomass 94 
grown in MRS was freeze-dried by a commercial culture company (Fermlabs Ltd, Finland) 95 
using maltodextrins as cryoprotectant. Then, 0.1 g freeze-dried bacteria were used to 96 
inoculate 10 ml of the MRS media containing 10 µl ml
-1
 tritiated thymidine to obtain, after 97 
overnight growth, labelled bacteria. 98 
 The model pathogens for the study, Clostridium difficile DSM 1296, Escherichia coli NTCT 99 
9001, Salmonella enterica serovar Typhimurium ATCC 12028, Streptococcus mutans ATCC 100 
2517S, and Enterobacter sakazakii ATCC 29544 were grown in Gifu Anaerobic Medium 101 
(GAM) (Nissui Pharmaceutical, Tokyo, Japan) for 18 h at 37 °C. All strains were incubated 102 
under anaerobic conditions (10 % H2, 10 % CO2 and 80 % N2; Concept 400 anaerobic 103 
chamber, Ruskinn Technology, Leeds, UK).  104 
1.2.2. Heat-tolerance assay 105 
Heat-tolerance of derivative strains was tested in PBS after incubation of strains at 60 
0
C,    106 
70 ºC and 80 ºC. First, strains were cultured in GAM broth in anaerobic conditions at 37 °C 107 
(24 h for lactobacilli and 48 h for bifidobacteria); bacteria were harvested by centrifugation, 108 
washed twice with PBS and resuspended into PBS for heat-tolerance tests. Samples were 109 
taken during incubation (at 1, 2, 5 and 10 min) and 1 ml plated on GAM agar. In order to 110 
verify that the obtained derivative strains belonged to the expected species, to exclude 111 
contaminations with other microorganisms, original and heat-tolerant strains were identified 112 
by sequencing the partial 16S ribosomal DNA (rDNA) gene (Kullen et al. 2000). 113 
1.2.3. Mucus adhesion assay 114 
Human colonic mucus was collected as previously described (Ouwehand et al. 2002) and 115 
stored at -80 °C until use. Before use the protein concentration of the mucus was determined 116 
and diluted to 0.5 mg/ml in HEPES (N-2-hydroxyethylpiperazine-N-2-ethanosulphonic acid)-117 
Hanks buffer (HH; 10 mM HEPES, pH 7.4). 100 µl of mucus was immobilized into 118 
polystyrene microtitre plate wells (Maxisorp, Nunc, Roskilde, Denmark) by incubation at      119 
4 °C for 18 h. 120 
Radiolabelled pathogenic bacteria were collected by centrifugation at 1500 g for 7 min and 121 
washed twice with PBS and the absorbance (A600) was normalised to 0.25 (aprox. 10
8
 122 
cfu/ml).  Of this, 100 µl was added to the wells and incubated at 37 °C for 1 h. The wells 123 
were washed twice with 200 µl HH buffer to remove unattached bacteria and the adhered 124 
bacteria were released and lysed  by incubation at 60 °C for 1 h in 1 % (wt/vol) sodium 125 
dodecyl sulphate in 0.1 M NaOH (200 µl per well). The contents of each well were added to 126 
1 ml of scintillation liquid (OptiPhase “HiSafe 3”, Wallac, Milton Keynes, UK) in a 127 
microcentrifuge tube and the radioactivity was measured by liquid scintillation. Adhesion 128 
was expressed as the percentage of radioactivity recovered after adhesion relative to the 129 
radioactivity of the bacterial suspension added to the immobilized mucus. Adhesion was 130 
determined in three independent experiments, and each assay was performed in triplicate. 131 
1.2.4. Inhibition of pathogen adhesion to colonic mucus 132 
  133 
To test the ability of the probiotic strains to inhibit the adhesion of pathogens the procedure 134 
described by Collado et al. (2005) was used. In brief, unlabelled probiotic bacteria (100 µl, 135 
10
8
 cells ml
-1
 approximately) were added to the wells and incubated for 1 h at 37 °C. Non-136 
bound probiotic bacteria were removed by washing twice with HH-buffer and then, 137 
radiolabelled pathogens (100 µl, 10
8
 cells ml
-1
 approximately) were added to the wells and 138 
incubated at 37 °C for 1
 
h.  After this second incubation, unbound bacteria were washed and 139 
bound bacteria were lysed as described in adhesion assays. Radioactivity was assessed by 140 
liquid scintillation. The adhesion inhibition was calculated as the difference between the 141 
adhesion of the pathogen in the absence (control) and presence of probiotic strains. Inhibition 142 
was determined in three independent experiments and each assay was performed in triplicate.  143 
 144 
1.2.5. Displacement of pathogens adhered to colonic mucus.  145 
The ability of the studied probiotic strains to displace already adhered pathogens was 146 
assessed according to Collado et al. (2005). Radiolabelled pathogens were added to the wells 147 
containing mucus and incubated for 1 h at 37 °C. After the washing and removing of 148 
unbound pathogens, unlabelled probiotic strains were added, and the plate was incubated for 149 
1 h at 37 °C. After that, the wells were washed and the bound bacteria were recovered after 150 
lysis and radioactivity was measured. Displacement of pathogens was calculated as the 151 
difference in adhesion before versus after addition of probiotics. Three independent 152 
experiments were carried out. Each assay was performed in triplicate to calculate intra-assay 153 
variation. 154 
 155 
1.2.6. Competitive exclusion of pathogens adhered to colonic mucus.  156 
Equal quantities of bacterial suspension of probiotic and radiolabeled pathogens were mixed 157 
and added to the immobilized mucous. This was incubated for 1 h at 37°C. The cells of the 158 
pathogen bound to the mucous were released and lysed as above. Exclusion of pathogens was 159 
calculated as the difference between the adhesion of pathogens before and after the addition 160 
of the probiotic strains. 161 
 162 
1.2.7. Statistics 163 
Statistical analysis was performed using the SPSS 11.0 software (SPSS Inc, Chicago, IL, 164 
USA). Data were subjected to one-way analysis of variance (ANOVA) and the Student-165 
Newman-Keuls (S-N-K) test was used for comparison of the means, where appropriate.        166 
P < 0.05 was considered statistically significant. 167 
 168 
1.3. Results 169 
1.3.1. Heat-tolerance of the strains 170 
Heat-tolerance of the derivative strains obtained in the study was compared to the 171 
corresponding parental strain by incubating strains in PBS at different temperatures (60 °C, 172 
70 °C and 80 °C). Enhanced heat-tolerance (1700-fold) of the derivative strain was obtained 173 
for Lactobacillus rhamnosus GG (after 20 min heat-treatment at 60 °C) and Bifidobacterium 174 
lactis Bb-12 (after 20 min at 60 °C), with viability increasing 1700-fold (P = 0.0002) and 16-175 
fold (P = 0.0003), respectively (Figure 1). Regarding Bifidobacterium animalis IF20/1 and 176 
Lactobacillus casei Shirota the stress adaptation did not enhance the thermo-tolerance of the 177 
strains (Figure 1). Increased tolerance was obtained also at temperatures 70 °C and 80 °C, 178 
although the temperatures were already lethal also for derivative strains, thus the results from 179 
60 °C are only shown. 180 
1.3.2. Adhesion of probiotics to human colonic mucus  181 
The adhesion of each strain was tested, and the effect of the heat-shock procedure as well as 182 
freeze drying on this was observed (Fig. 2). 183 
The fresh cultures of heat treated probiotic strains did not show any changes in their adhesion 184 
abilities to human colonic mucus, except for strain Bb12 that significantly increased its 185 
adhesiveness from approximately 6 % to approximately 10 % (Fig. 2B).  186 
Freeze-drying, however, caused a significant decrease of the adhesion capabilities for all 187 
strains tested except SHI (Fig. 2). 188 
When the heat treated variant of LGG was freeze-dried (LGG HS FD), a further significant 189 
decrease was observed in its adhesiveness (Fig. 2A). Heat treated, freeze-dried strains Bb12 190 
and IF20/1 (Bb12 HS FD and IF20/1 HS FD) showed no significant differences to their 191 
original freeze dried counterparts (Fig. 2B and D). Again, SHI showed no significant 192 
differences between the original and any of its derivatives (Fig. 2C).  193 
No protective mechanism was noted by heat treating the bacteria prior to freeze drying (Fig. 194 
2). This may be due to the pre-culturing of the strains for this experiment where all 195 
derivatives are grown at 37°C which may result in the loss of heat-tolerance and hence no 196 
differences may be seen in their stability during freeze-drying. The heat-tolerant strains 197 
should rather constantly be exposed to the heat stress prior to performing this assay. 198 
Adhesion of the pathogens was also studied and the tested strains showed low adhesion 199 
potential. S. typhimurium showed the lowest adhesion of 0.25 %, followed by E. sakazakii at 200 
0.4 %. E. coli and S. mutans showed an adhesion of 0.8 % and C. difficile displayed the most 201 
marked adhesion to colonic mucus at 1 %.                                                             202 
 203 
1.3.3. Adhesion mechanisms 204 
1.3.3.1. Inhibition by exclusion 205 
The effect of heat-tolerance acquisition and freeze drying on ability of the four probiotic 206 
strains to inhibit the adhesion of the pathogens was tested (results not shown). We only found 207 
a significant decrease in the ability of freeze-dried derivatives of Bb12 HS, SHI and SHI HS 208 
and IF20/1 in excluding E. coli. Heat tolerance and freeze drying of LGG HS FD showed no 209 
significant effect on its ability to exclude this pathogen and no significant changes were 210 
observed for any of the other pathogens tested. 211 
1.3.3.2. Displacement of pathogens adhered to intestinal mucus 212 
All original and heat-tolerant probiotic strains were capable of displacing all pre-adhered 213 
tested pathogens (Table 1). However, freeze drying the probiotics has a largely damaging 214 
effect on the displacement abilities of these strains, apart from IF20/1 whose displacement 215 
ability is not changed significantly. The displacement of E. coli by SHI was significantly 216 
reduced (P = 0.0001) by freeze drying the original and the heat treated derivatives, the latter 217 
losing its displacement ability fully. The same derivatives of SHI significantly reduce their 218 
abilities to displace S. typhimurium (P = 0.002), C. difficile (P = 0.002) and E. sakazakii (P = 219 
0.001).  Bb12 FD and its derivative Bb12 HS FD also significantly decrease the displacement 220 
of C. difficile and S. mutans, and only Bb12 HS FD strain loses its displacement ability 221 
towards E. sakazakii. LGG FD shows a significant decrease (P = 0.033) and a further 222 
significant decrease (P = 0.0001), when the heat treated strain is freeze dried, losing its 223 
displacement capacity (-58.7 %) against E. sakazakii.  224 
1.3.3.3. Competitive exclusion to intestinal mucus 225 
The results of the inhibition by competition are shown in table 1. The freeze dried derivatives 226 
differed significantly in their ability to competitively exclude the pathogens. No significant 227 
differences in inhibition of E. coli were observed for any strain. With respect to S. 228 
typhimurium, only IF20/1 had an effect, with IF20/1 FD showing a significant reduction (P = 229 
0.002) in inhibition to this pathogen when compared to the fresh cultures or IF20/1 HS FD. 230 
C. difficile was not outcompeted by LGG original, but the strains ability to outcompete this 231 
pathogen was significantly increased (P = 0.014) by LGG FD and LGG HS FD variants.  232 
This was repeated for Bb12 against C. difficile where the freeze dried variants increased the 233 
ability of Bb12 to outcompete C. difficile significantly (P = 0.021). SHI FD showed a 234 
significant decrease (P = 0.011) in its ability to outcompete the same pathogen without 235 
observing the same effect for the SHI HS derivative strain. However, no statistically 236 
significant differences were observed for the IF20/1 strains. The treatment of all probiotics 237 
resulted in no significant differences observed in their ability to outcompete E. sakazakii 238 
except LGG FD, where a significant increase (P = 0.037) was seen. Finally, the only 239 
significant difference observed for the competition with S. mutans was again seen for IF20/1 240 
FD, where a significant decrease (P = 0.032) was observed.  241 
 242 
1.4. Discussion 243 
There is increasing interest in the incorporation of probiotics into foods other than fermented 244 
dairy products due to consumer demand for a wider range of products. However, there are 245 
technological challenges in the incorporation of probiotics to non-dairy products 246 
(Grześkowiak et al. 2011). Probiotics should remain viable in the end product. The acidity of 247 
the product as well as the high temperatures used for processing of the products can cause 248 
challenges in maintaining the viability. The ability to withstand stress during processing and 249 
storage of products is important and thermotolerant probiotics are of great interest in this area 250 
(Saarela et al. 2004). However, the probiotic properties such as adhesion to the intestinal 251 
mucus should not be altered by stress adaptation. In this work, heat adaptation was used to 252 
enhance heat-tolerance of probiotic strains and the effect of stress adaptation as well as freeze 253 
drying on the mucus adhesion and the ability to exclude, displace or outcompete pathogens 254 
were evaluated.  255 
Stress adaptation of strains can be done by exposing strains to lethal or sub-lethal conditions ( 256 
(Alvarez-Ordonez et al. 2008; Annous et al. 1999). Several factors can affect the heat-257 
tolerance of a strain including growth medium and pH, however other stresses such as use of 258 
ethanol, hydrogen peroxide, oxygen, pressure, starvation or osmotic environment can lead to 259 
increased heat- or acid stress response by cross protection. The stress adaptation is a species- 260 
or even strain-specific characteristic involving the fatty acid composition of the membrane ( 261 
(Alvarez-Ordonez et al. 2008; Annous et al. 1999). 262 
 263 
The effects of heat stress response have been studied in probiotic bacteria to improve their 264 
performance during food processing. Desmond et al. (2001) showed that heat adapted (at 52 265 
°C for 15 min) L. paracasei NFBC 338 exhibited a 300- and 700-fold increase in 266 
thermotolerance at 60 °C in MRS and reconstituted skim milk, respectively. Pressure pre-267 
treatment of L. rhamnosus GG increased survival of the strain when exposed to 60 °C 268 
indicating cross protection (Ananta et al. 2004) while heat and acid responses did not present 269 
significant cross-protection in Propionibacterium freudenreichii (Leverrier et al. 2004). In this 270 
work, a considerably enhanced heat-tolerance (1700-fold) was obtained with Lactobacillus 271 
rhamnosus GG and enhanced heat-tolerance (16-fold) was obtained with Bifidobacterium 272 
lactis Bb-12 when strains were exposed to sublethal heat. However, for two other strains, B. 273 
animalis IF20/1 and L. casei Shirota, heat adaptation did not lead to significantly increased 274 
heat-tolerance.  275 
The impact of the freeze-drying process on probiotic adhesion properties was studied and 276 
compared to the original strains. The stress adapted strains obtained from exposure to 277 
increasing heat were expected to show increased survival after freeze-drying as this adaption 278 
is thought to protect the bacterial membrane which is the primary site for dehydration damage 279 
(Castro et al. 1997). Bacterial death during freeze-drying is due to osmotic shock and 280 
formation of intracellular ice and recrystallisation (Heckl, 1985).  During freeze-drying the 281 
frozen water is removed by sublimation, in an effort to reduce damage to biological 282 
structures. However, the viability of the freeze-dried microorganism depends on several 283 
factors such as the strain used, bacterial cell size, and efficacy of the cryoprotectant (Fonseca 284 
et al. 2000). Maltodextrins have previously been shown to increase survival of lactic acid 285 
bacteria during freeze-drying due to direct interactions with proteins and membranes (De 286 
Guilio et al. 2005). 287 
In this study, freeze drying of probiotics was found to have an effect on adhesion potential, 288 
showing an overall significant decrease in the ability of the freeze dried probiotic to exclude, 289 
displace or outcompete certain pathogens. Only in isolated cases a significant increase was 290 
noticed. These increases were observed for Lactobacillus rhamnosus GG and 291 
Bifidobacterium lactis Bb-12 in inhibition by competition assays. Out of all the combinations 292 
of probiotic derivatives and pathogen tested here, there does not seem to be a trend in effect 293 
of freeze drying on adhesion potential. The effect of freeze drying appeared to be strain 294 
dependent and L. casei Shirota properties appeared more sensitive to freeze drying than the 295 
other strains as it showed more frequent decreases in ability to adhere.  296 
Taken together, it appears that the tolerance to processing conditions and stress induced 297 
during processing and storage can be enhanced by traditional conditioning methods. 298 
However, manufacturing processes, such as freeze-drying, may affect strain properties and 299 
should be assessed independently. Stress-tolerant strains may be new options for future 300 
probiotic technology, providing that there are no changes in their original properties, to 301 
enable the use of derived probiotics in same target groups and populations as earlier reported. 302 
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Table 1. The percentage inhibition of model pathogens by the study strains in a human intestinal mucus model. Results are shown as mean ± 427 
standard deviation and they are represented as percentages compared to adhesion inhibition of pathogen strains without probiotic strains 428 
presence (taken as 0 %). 429 
 430 
a, b 
Columns with different superscripts differ significantly (P < 0.05) 431 
Probiotic % pathogen inhibition by exclusion % pathogen displacement % pathogen inhibition by competition 
 E. coli 
S. 
typhimurium 
C. difficile 
E. 
sakazakii 
S. mutans E. coli 
S. 
typhimurium 
C. difficile E. sakazakii S. mutans E. coli 
S. 
typhimurium 
C. difficile E. sakazakii S. mutans 
LGG 22,0 ± 6,4 -0,54 ± 1,9 -95,9 ± 10,0 -17,9 ± 2,7 -3,3 ± 1,5 36,3 ± 2,4 58,3 ± 9,4 58,4 ± 1,4 63,8 ± 1,5
a
 62,6 ± 1,0 -6,5 ± 1,5 16,3 ± 4,3 -14,0 ± 1,4
a
 -19,9 ± 1,4
a
 -7,2 ± 3,4 
LGG HS 10,7 ± 6,1 -38,3 ± 5,3 -53,2 ± 5,6 -53,2 ± 5,6 -29,7 ± 3,7 49,0 ± 1,3 57,6 ± 1,1 40,6 ± 2,9 59,0 ± 1,6
a
 62,1 ± 1,1 14,4 ± 1,5 16,4 ± 0.8 6,1 ± 3,9
a
 -5,0 ± 1,5
a
 13,6 ± 2,4 
LGG FD -18,6±10,3 33,0 ± 6,3 -23,1 ± 9,5 -23,1 ± 9,5 28,0 ± 3,0 18,4 ± 1,1 26,2 ± 1,0 21,4 ± 1,0 11,6 ± 5,8
b
 32,2 ± 9,3 11,0 ± 3,0 24,6 ± 6,0 39,4 ± 6,8
b
 35,9 ± 8,0
b
 22,1 ± 3,7 
LGG HS FD -20,8 ± 14,2 35,9 ± 3,9 -19,2 ± 1,5 -19,2 ± 1,5 42,0 ± 11,0 23,9 ± 6,5 16,2 ± 1,3 25,5 ± 3,1 -58,7 ± 1,0
c
 29,3 ± 7,4 21,6 ± 3,2 34,3 ± 3,5 25,8 ± 0,73
b
 -14,3 ± 0,8
a
 22,13 ± 3,2 
P value 0,23 0,29 0,771 0,834 0,142 0,519 0,057 0,456 0,0001 0,065 0,379 0,166 0,014 0,037 0,738 
Bb12 32,3 ± 11,1
a
 -18,5 ± 4,5 -35,3 ± 5,0 8,4 ± 1,5 -22,2 ± 4,6 57,3 ± 1,2 61,6 ± 8,1 65,7 ± 1,2
a
 61,8 ± 17,9
a
 68,3 ± 7,1
a
 19,5 ± 1,0 36,8 ± 9,7 -0,6 ± 1,5
a
 -5,1 ± 2,1 19,1 ± 2,2 
Bb12 HS 21,2 ± 1,5
a
 -17,8 ± 4,7 -49,3 ± 5,1 0,8 ± 2,6 2,2 ± 3,3 54,1 ± 1,4 50,0 ± 1,7 56,8 ± 1,7
a
 61,2 ± 19,2
a
 58,9 ± 13,5
a
 21,6 ± 2,0 34,8 ± 3,6 6,8 ± 0,9
a
 -9,4 ± 5,6 3,7 ± 3,3 
Bb12 FD 14,5 ± 3,7
a
 19,6 ± 2,6 -11,5 ± 1,1 -34,9 ± 1,2 10,2 ± 1,1 27,3 ± 6,7 32,2 ± 6,8 23,0 ± 1,3
b
 21,6 ± 1,3
a
 31,4 ± 3,4
b
 20,1 ± 1,7 32,1 ± 3,1 51,9 ± 6,2
b
 24,7 ± 1,8 17,1 ± 5,4 
Bb12 HS FD -41,3 ± 1,5
b
 24,6 ± 11,0 -25,3 ± 6,2 -25,3 ± 6,2 -12,7 ± 1,5 28,2 ± 5,9 19,6 ± 8,8 -0,4 ± 0,4
b
 -30,3 ± 6,2
b
 17,4 ± 7,7
b
 23,3 ± 2,3 28,8 ± 2,2 43,2 ± 1,1
b
 33,2 ± 7,0 39,2 ± 6,7 
P value 0,01 0,691 0,899 0,262 0,856 0,126 0,1 0,008 0,007 0,011 0,958 0,759 0,021 0,171 0.686 
SHI 31,5 ± 8,0
a
 19,1 ± 2,1 -42,1 ± 3,7 15,1 ± 2,1 16,9 ± 1,1 55,2 ± 7,8
a
 60,9 ± 7,0
a
 62,2 ± 1,0
a
 59,1 ± 13,4
a
 33,7 ± 1,8 20,5 ± 7,4 31,0 ± 3,7 42,9 ± 2,9
a
 -4,1 ± 0,5 18,6 ± 2,8 
SHI HS 29,8 ± 1,3
a
 19,5 ± 1,8 -47,8 ± 4,4 10,1 ± 1,8 -8,7 ± 0,3 53,2 ± 8,5
a
 58,0 ± 9,77
a
 56,8 ± 1,4
a
 62,8 ± 11,6
a
 60,1 ± 6,7 5,7 ± 0,5 12,2 ± 4,4 2,8 ± 1,3
a
 -6,7 ± 3,8 18,7 ± 2,1 
SHI FD -24,1 ± 1,0
b
 35,0 ± 7,7 -9,5 ± 1,5 11,7 ± 0,9 -25,4 ± 1,1 8,5 ± 3,3
b
 -4,1 ± 0,4
b
 10,0 ± 1,8
b
 -15,5 ± 6,2
b
 23,3 ± 3,1 18,7 ± 0,8 16,1 ± 4,0 -47,7 ± 3,1
b
 20,5 ± 0,9 27,3 ± 9,2 
SHI HS FD -38,3 ± 1,6
b
 33,2 ± 4,7 -40,8 ± 1,6 -45,7 ± 1,3 8,8 ± 0,5 -4,1 ± 0,5
b
 12,9 ± 1,3
b
 -2,6 ± 0,4
b
 12,6 ± 1,1
b
 32,5 ± 3,0 15,6 ± 4,0 32,6 ± 1,2 49,1 ± 8,3
a
 23,4 ± 5,2 35,7 ± 2,5 
P value 0,006 0,791 0,8 0,079 0,519 0,0001 0,002 0,002 0,001 0,133 0,229 0,173 0,011 0,613 0,893 
IF20/1 36,8 ± 1,7
a
 30,3 ± 2,1 -36,8 ± 4,6 28,2 ± 2,3 17,5 ± 2,1 49,0 ± 8,0 57,4 ± 1,4 36,9 ± 3,5 59,6 ± 1,8 58,7 ± 13,5 22,4 ± 2,2 26,1 ± 1,1
a
 -9,5 ± 0,7 -15,4 ± 1,8 19,6 ± 1,3
a
 
IF20/1 HS 19,1 ± 2,9
a
 -26,4 ± 5,8 -33,8 ± 4,1 8,2 ± 0,2 -8,9 ± 0,4 53,5 ± 7,0 57,1 ± 1,6 57,6 ± 1,5 54,6 ± 2,1 65,5 ± 7,7 25,9 ± 6,0 31,9 ± 7,6
a
 18,8 ± 2,5 -6,6 ± 1,4 15,0 ± 1,5
a
 
IF20/1 FD -44,9 ± 4,0
b
 -7,5 ± 0,5 -22,9 ± 0,9 33,1 ± 7,9 -44,3 ± 1,1 28,6 ± 3,5 44,6 ± 6,8 24,7 ± 5,1 32,8 ± 8,3 35,0 ± 4,3 17,6 ± 5,9 -6,2 ± 0,7
b
 35,0 ± 1,6 -16,5 ± 2,7 -24,5 ± 0,7
b
 
IF20/1 HS 
FD 
21,1 ± 0,7
a
 38,5 ± 1,4 -20,4 ± 0,92 -37,1 ± 1,0 -45,6 ± 7,2 35,5 ± 4,1 49,6 ± 7,9 23,6 ± 1,0 30,5 ± 1,1 39,7 ± 7,4 27,3 ± 7,5 19,4 ± 5,7
a
 17,1 ± 0,9 32,0 ± 6,9 31,9 ± 7,5
a
 
P value 0,043 0,451 0,977 0,084 0,201 0,059 0,841 0,583 0,472 0,112 0,656 0,002 0,071 0,061 0,032 
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Figure 1. Heat-tolerance of the derivative strains when compared to parental strains during 451 
incubation at 60 
0
C. Parental strains marked as open triangle, derivative strains marked with 452 
closed triangles. Each value is a mean ± SD for 3 determinations. 453 
 454 
Figure 2. Adhesion of probiotic strains LGG (A), BB12 (B), SHI (C) and IF (D) to human 455 
colonic mucus in their original form, the heat-shocked derivative (HS), the freeze dried form 456 
(FD) and the heat-shocked derivative freeze dried (HS FD). Results are expressed as the 457 
percentage of radioactivity recovered from immobilised mucus compared to radioactivity 458 
added to mucus (mean and SD).  459 
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